| Risk of COVID-19 in health-care workers in Denmark: an observational cohort study K Iversen, H Bundgaard, RB Hasselbalch, JH Kristensen, PB Nielsen, ... The Lancet Infectious Diseases 20 (12), 1401-1408, 2020 | 468 | 2020 |
| Effectiveness of adding a mask recommendation to other public health measures to prevent SARS-CoV-2 infection in Danish mask wearers: a randomized controlled trial H Bundgaard, JS Bundgaard, DET Raaschou-Pedersen, C von Buchwald, ... Annals of internal medicine 174 (3), 335-343, 2021 | 452 | 2021 |
| Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors L Pérez-Alós, JJA Armenteros, JR Madsen, CB Hansen, I Jarlhelt, ... Nature communications 13 (1), 1614, 2022 | 146 | 2022 |
| Comparison of 16 serological SARS-CoV-2 immunoassays in 16 clinical laboratories LH Harritshøj, M Gybel-Brask, S Afzal, PR Kamstrup, CS Jørgensen, ... Journal of Clinical Microbiology 59 (5), 10.1128/jcm. 02596-20, 2021 | 132 | 2021 |
| Reconstruction of the chronic anterior unstable sternoclavicular joint using a tendon autograft: medium-term to long-term follow-up results K Bak, K Fogh Journal of Shoulder and Elbow Surgery 23 (2), 245-250, 2014 | 68 | 2014 |
| Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections NB Stærke, J Reekie, H Nielsen, T Benfield, L Wiese, LS Knudsen, ... Nature communications 13 (1), 4466, 2022 | 57 | 2022 |
| Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study OS Søgaard, J Reekie, IS Johansen, H Nielsen, T Benfield, L Wiese, ... Clinical Microbiology and Infection 28 (8), 1126-1133, 2022 | 39 | 2022 |
| Humoral response to two doses of BNT162b2 vaccination in people with HIV LD Heftdal, AD Knudsen, SR Hamm, CB Hansen, DL Møller, ... Journal of internal medicine 291 (4), 513-518, 2022 | 35 | 2022 |
| Decline in antibody concentration 6 months after two doses of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients and healthy controls SR Hamm, DL Møller, L Pérez-Alós, CB Hansen, MM Pries-Heje, ... Frontiers in Immunology 13, 832501, 2022 | 31 | 2022 |
| Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming CB Hansen, I Jarlhelt, RB Hasselbalch, SR Hamm, K Fogh, ... Journal of Internal Medicine 290 (6), 1272, 2021 | 18 | 2021 |
| Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen JR Madsen, JPS Nielsen, K Fogh, CB Hansen, PB Nielsen, T Lange, ... Open forum infectious diseases 8 (8), ofab273, 2021 | 17 | 2021 |
| Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity LL Dietz, AK Juhl, OS Søgaard, J Reekie, H Nielsen, IS Johansen, ... Communications medicine 3 (1), 58, 2023 | 16 | 2023 |
| Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark K Fogh, ARR Eriksen, RB Hasselbalch, ES Kristensen, H Bundgaard, ... BMC infectious diseases 22 (1), 143, 2022 | 15 | 2022 |
| Testing Denmark: a Danish nationwide surveillance study of COVID-19 K Fogh, JE Strange, BFSS Scharff, ARR Eriksen, RB Hasselbalch, ... Microbiology spectrum 9 (3), e01330-21, 2021 | 15 | 2021 |
| Self-reported long COVID and its association with the presence of SARS-CoV-2 antibodies in a Danish cohort up to 12 months after infection K Fogh, TG Larsen, CB Hansen, RB Hasselbalch, ARR Eriksen, ... Microbiology spectrum 10 (6), e02537-22, 2022 | 13 | 2022 |
| Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers K Iversen, JH Kristensen, RB Hasselbalch, M Pries-Heje, PB Nielsen, ... Clinical Microbiology and Infection 28 (5), 710-717, 2022 | 13 | 2022 |
| Risk factors for being seronegative following SARS-CoV-2 infection in a large cohort of health care workers in Denmark CK Johannesen, O Rezahosseini, M Gybel-Brask, JH Kristensen, ... Microbiology spectrum 9 (2), e00904-21, 2021 | 12 | 2021 |
| Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases ZB Harboe, SR Hamm, L Pérez-Alós, P Sivapalan, H Priemé, T Wilcke, ... BMJ open respiratory research 9 (1), e001268, 2022 | 11 | 2022 |
| SARS-CoV-2 antibody prevalence among homeless people and shelter workers in Denmark: a nationwide cross-sectional study ARR Eriksen, K Fogh, RB Hasselbalch, H Bundgaard, SD Nielsen, ... BMC public health 22 (1), 1261, 2022 | 10 | 2022 |
| Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV … O Rezahosseini, SR Hamm, LD Heftdal, L Pérez-Alós, DL Møller, M Perch, ... Frontiers in immunology 13, 1075423, 2023 | 8 | 2023 |
